Literature DB >> 27586509

The influence of follow-up on DS02 low-dose ranges with a significant excess relative risk of all solid cancer in the Japanese A-bomb survivors.

Linda Walsh1, Uwe Schneider2.   

Abstract

Determinations of the lowest colon dose, D min, below which there is a statistically significant excess relative risk of all solid cancer, when analyses are restricted to the range [0, D min], are of current interest in research related to radiation protection and risk assessment. In reviewing recent cancer mortality reports on the Life Span Study (LSS) of Japanese A-bomb survivors, reported D min values were found to vary between different reports. The report 12 (follow-up: 1950-1990) found a D min of 50 mGy, but the most recent report 14 (follow-up: 1950-2003) found a D min of 200 mGy. There were small dosimetry changes between report 12, which used DS86, and report 14, which used DS02, but these changes are unlikely to account for a difference in D min of a factor of 4. This short communication examines the reasons for this difference in D min by presenting further investigations into D min using different trial values for D min and various follow-up time spans, all with the same DS02 dosimetry. Magnitudes of the low-dose risks in different dose ranges are also presented. It is shown here that the main influence on D min comes from the length of follow-up and a D min of 50 mGy may also be obtained with the most recent LSS mortality data and DS02, if a restricted follow-up is analyzed. A systematic trend was evident of lower D min values for earlier mortality follow-up periods, consistent with information from earlier LSS reports. Although it may seem surprising that the D min increases with longer follow-up and better statistics, this systematic trend appears to be a consequence of decreasing mortality risks with longer follow-up, even though the error bars on the risks are getting smaller with increasing follow-up. These systematic trends also persisted after accounting for differences between baseline cancer rates for two groups of survivors who were either proximal or distal to the A-bomb hypocenter. Similar systematic trends, although much less pronounced, were also found in the LSS cancer incidence data. Some evidence is provided here that results on low-dose radiation risks from earlier follow-up periods should not be ignored by radiation protection authorities, once the results from the new extended follow-ups are published. This is because of the possibility that the new data for extended follow-up beyond a certain calendar time, which pertain to very long times since exposure, may be contributing to an overall reduction in radiation related risks per unit dose compared to analogous risks determined from earlier follow-up periods, because of the risk effect modification of time since exposure.

Entities:  

Keywords:  Life Span Study; Low-dose research; Risk assessment

Mesh:

Year:  2016        PMID: 27586509     DOI: 10.1007/s00411-016-0667-0

Source DB:  PubMed          Journal:  Radiat Environ Biophys        ISSN: 0301-634X            Impact factor:   1.925


  12 in total

1.  Radiation-related cancer risks at low doses among atomic bomb survivors.

Authors:  D A Pierce; D L Preston
Journal:  Radiat Res       Date:  2000-08       Impact factor: 2.841

2.  Indications of the neutron effect contribution in the solid cancer data of the A-bomb survivors.

Authors:  Albrecht M Kellerer; Werner Rühm; Linda Walsh
Journal:  Health Phys       Date:  2006-06       Impact factor: 1.316

3.  Neutron relative biological effectiveness for solid cancer incidence in the Japanese A-bomb survivors: an analysis considering the degree of independent effects from γ-ray and neutron absorbed doses with hierarchical partitioning.

Authors:  Linda Walsh
Journal:  Radiat Environ Biophys       Date:  2012-11-17       Impact factor: 1.925

4.  Studies of the mortality of atomic bomb survivors. Report 12, Part I. Cancer: 1950-1990.

Authors:  D A Pierce; Y Shimizu; D L Preston; M Vaeth; K Mabuchi
Journal:  Radiat Res       Date:  1996-07       Impact factor: 2.841

5.  Studies of the mortality of atomic bomb survivors, Report 14, 1950-2003: an overview of cancer and noncancer diseases.

Authors:  Kotaro Ozasa; Yukiko Shimizu; Akihiko Suyama; Fumiyoshi Kasagi; Midori Soda; Eric J Grant; Ritsu Sakata; Hiromi Sugiyama; Kazunori Kodama
Journal:  Radiat Res       Date:  2011-12-15       Impact factor: 2.841

6.  Curvilinearity in the dose-response curve for cancer in Japanese atomic bomb survivors.

Authors:  M P Little; C R Muirhead
Journal:  Environ Health Perspect       Date:  1997-12       Impact factor: 9.031

7.  Curvature in the cancer mortality dose response in Japanese atomic bomb survivors: absence of evidence of threshold.

Authors:  M P Little; C R Muirhead
Journal:  Int J Radiat Biol       Date:  1998-10       Impact factor: 2.694

8.  Effect of recent changes in atomic bomb survivor dosimetry on cancer mortality risk estimates.

Authors:  Dale L Preston; Donald A Pierce; Yukiko Shimizu; Harry M Cullings; Shoichiro Fujita; Sachiyo Funamoto; Kazunori Kodama
Journal:  Radiat Res       Date:  2004-10       Impact factor: 2.841

9.  Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950-1997.

Authors:  Dale L Preston; Yukiko Shimizu; Donald A Pierce; Akihiko Suyama; Kiyohiko Mabuchi
Journal:  Radiat Res       Date:  2003-10       Impact factor: 2.841

10.  Solid cancer incidence in atomic bomb survivors: 1958-1998.

Authors:  D L Preston; E Ron; S Tokuoka; S Funamoto; N Nishi; M Soda; K Mabuchi; K Kodama
Journal:  Radiat Res       Date:  2007-07       Impact factor: 2.841

View more
  1 in total

1.  Effect of follow-up period on minimal-significant dose in the atomic-bomb survivor studies.

Authors:  John Cologne; Dale L Preston; Eric J Grant; Harry M Cullings; Kotaro Ozasa
Journal:  Radiat Environ Biophys       Date:  2017-11-21       Impact factor: 1.925

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.